Phentolamine continuous infusion in a patient with pheochromocytoma

American Journal of Health-System Pharmacy

Volumn 68, Issue 2, 2011, Pages 130-134

  McMillian, Wesley D ^a   Trombley, Bryan J ^b   Charash, William E ^c   Christian, Rose C ^c,d  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b Alice Hyde Medical Center   (United States)

^c Surgical Intensive Care Unit   (United States)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

Esmolol; Hypertension; Phenoxybenzamine; Phentolamine mesylate; Pheochromocytoma; Postoperative complications; Surgery; Sympatholytic agents

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ESMOLOL; FENTANYL; GLYCERYL TRINITRATE; LORAZEPAM; METIROSINE; METOPROLOL TARTRATE; MIDAZOLAM; NORADRENALIN; PHENOXYBENZAMINE; PHENTOLAMINE MESYLATE; PROPOFOL; VASOPRESSIN; ANTIHYPERTENSIVE AGENT; PHENTOLAMINE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CASE REPORT; CONTINUOUS INFUSION; FEMALE; HEART ARREST; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; LAPAROSCOPIC SURGERY; OUTPATIENT CARE; PHEOCHROMOCYTOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESUSCITATION; RISK REDUCTION; SURGICAL TECHNIQUE; ADRENAL TUMOR; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

ADRENAL GLAND NEOPLASMS; ADULT; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; PHENTOLAMINE; PHEOCHROMOCYTOMA; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 79955020806     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp090619     Document Type: Article

References (21)

1. Pacak K, Eisenhofer G, Ahlman H et al. Pheochromocytoma: recommendation for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab. 2007; 3:92-102. (Pubitemid 46146962)
2. Kinney MA, Narr BJ, Warner ME. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth. 2002; 16:359-69. (Pubitemid 34701193)
3. Adler JT, Meyer-Rochow GY, Chen H et al. Pheochromocytoma: current approaches and future directions. Oncologist. 2008; 13:779-93.
4. Plouin PF, Duclos JM, Soppelsa F et al. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab. 2001; 86:1480-6. (Pubitemid 32374890)
5. Kobal SL, Paran E, Jamal A et al. Pheochromocytoma: cyclic attacks of hypertension alternating with hypotension. Nat Clin Pract Cardiovasc Med. 2008; 5:53-7.
6. Barnes BJ, Gerst C, Smith JR et al. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation. Pharmacotherapy. 2006; 26:23-33. (Pubitemid 43082924)
7. Sessler CN, Gosnell M, Grap MJ et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care patients. Am J Respir Crit Care Med. 2002; 166:1338-44. (Pubitemid 35292699)
8. Roizen MF, Schreider BD, Hassan SZ. Anesthesia for patients with pheochromocytoma. Anesthesiol Clin North Am. 1987; 157:269-75.
9. Steinsapir J, Carr AA, Prisant LM et al. Metyrosine and pheochromocytoma. Arch Intern Med. 1997; 157:901-6. (Pubitemid 28337041)
10. Dibenzylene (phenoxybenzamine) package insert. Bradenton, FL: Well-Spring Pharmaceutical Corporation; 2008 Mar.
11. Kinney MA, Warner ME, vanHeerden JA et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg. 2000; 91:1118-23.
12. Matthews MR, Al-kasspooles MF, Caruso DM et al. Management of a trauma patient with incidental pheochromocytoma. J Trauma. 1999; 46:738-44.
13. Phentolamine mesylate package insert. Bedford, OH: Bedford Laboratories; 1999 May.
14. Demser (metyrosine) capsules package insert. West Point, PA: Merck & Co.; 2007 May.
15. Torre JJ, Bloomgarden ZT, Dickey RA et al. American Association of Clinical Endocrinologists medical guidelines for the diagnosis and treatment of hypertension. Endocr Pract. 2006; 12:193-222.
16. Engelbrecht ER, Hugill JT, Graves HB. Anaesthetic management of pheochromocytoma. Can Anaest Soc J. 1966; 13:598-606.
17. Myklejord DJ. Undiagnosed pheochromocytoma: the anesthesiologist nightmare. Clin Med Res. 2004; 2:59-62.
18. Gabrielson GV, Guffin AV, Kaplan JA et al. Continuous intravenous infusion of phentolamine and esmolol for preoperative and intraoperative adrenergic blockade in patients with pheochromocytoma. J Cardiothorac Anesth. 1987; 6:554-8.
19. Grasselli G, Foti G, Patroniti N et al. Extracorporeal cardiopulmonary support for cardiogenic shock caused by pheochromocytoma: a case report and literature review. Anesthesiology. 2008; 108:959-62. (Pubitemid 351589493)
20. Mihm FG, Sandhu JS, Brown MD et al. Short-acting beta-blockade as initial drug therapy in pheochromocytoma. Crit Care Med. 1990; 18:673-4. (Pubitemid 20185615)
21. Turner P. Some clinical applications of receptor concepts. Circ Res. 1980; 46(suppl 1):10-4.